OPA1 and optic atrophy: As an example, expression of a the MGM1-OPA1 chimeric construct was used to model both dominant and recessive human pathological mutations in OPA1, associated to optic atrophy (DOA), to DOA+ and to pathologies associated to mtDNA depletion [127,128].